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I
W
P
A
T
H
B
M
H
N
O
c
s
B
s
v
M
b
a
r
R
c
i
e
s
c
t
C
c
i
F
F
S
N
M
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 2 , N O . 2 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 0 8 . 0 7 . 0 1 0ntracoronary Electrocardiogram Recording
ith a Bare-Wire System
erioperative ST-Segment Elevation in the Intracoronary Electrocardiogram Is
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bjectives With an intracoronary electrocardiogram (IcECG) recording with insulated polymer-
oated guidewire without balloon catheter, we sought to examine the association between ST-
egment elevation in the IcECG after elective stenting and myocardial injury.
ackground An IcECG is a sensitive method to detect local myocardial ischemia. Occasionally, per-
istent ST-segment elevation in the IcECG was recorded after successful coronary intervention. Con-
entionally IcECG was recorded with a guidewire and over-the-wire system.
ethods Patients who underwent elective stenting were enrolled (n  339). The IcECG both at
aseline and after procedure were obtained with a guidewire with an insulating coated shaft suit-
ble for IcECG recording. The presence of chest pain after percutaneous coronary intervention was
ecorded. Cardiac biomarkers were examined 18 h after the procedure.
esults The ST-segment elevation in the IcECG after procedure was recorded in 65 patients, and no
hange was recorded in 274 patients. Troponin-T, creatine phosphokinase, and creatine kinase MB
soform after the procedure were signiﬁcantly higher in patients with post-procedural ST-segment
levation in the IcECG than patients without ST-segment elevation. Multivariate analysis demon-
trated that ST-segment elevation in the IcECG is an independent predictor of post-procedural myo-
ardial injury. The incidence of ST-segment elevation in the IcECG was signiﬁcantly higher in pa-
ients with post-procedural chest pain than patients without chest pain (p  0.001).
onclusions We demonstrated a facile method to record IcECG with a guidewire with a polymer-
oated shaft. The IcECG is a useful method for predicting post-procedural myocardial
njuries. (J Am Coll Cardiol Intv 2009;2:127–35) © 2009 by the American College of Cardiology
oundation
rom the *Department of Cardiology, Chubu Rosai Hospital, Nagoya, Japan; †Department of Internal Medicine, Aichi-Gakuin
chool of Dentistry, Nagoya, Japan; and the ‡Department of Cardiology, Nagoya University Graduate School of Medicine,
agoya, Japan.anuscript received April 15, 2008; revised manuscript received July 16, 2008, accepted July 30, 2008.
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128ost-procedural myocardial injury after apparent uncompli-
ated percutaneous coronary intervention (PCI) is not uncom-
on (1–3). Previously subclinical creatine kinase-MB (CK-
B) elevation in 5% to 30% of patients after successful PCI
as reported. Some biochemical markers are more sensitive
nd specific in detecting myocardial damages.
Formerly, modest elevations of cardiac enzymes after suc-
essful PCI were considered relatively benign, and clinical
mplications of this phenomenon were not fully investigated.
ecently, some trials demonstrated that elevated cardiac bi-
markers after apparently successful PCI were associated with
ncreased risks of adverse cardiac events (4–6).
Intracoronary electrocardiogram (IcECG) with a guidewire
s a unipolar electrode represents local epicardial ECG. Unipo-
ar IcECG seemed to be more sensitive than surface ECG for
etecting local ischemia during coronary interventions (7,8).
ome studies demonstrated IcECG can be used to assess
yocardial viability in stable angina and acute myocardial
nfarctions (9,10).
Previously, an over-the-wire or monorail catheter had to be
crossed at the target lesion to pro-
vide insulation of the guidewire in
the part proximal to the stenosis
during IcECG recording (9).
However, in a case of severe ste-
nosis or coronary occlusion, severe
ischemic changes of IcECG
might occur if a balloon catheter is
wedged into the stenosis. There-
fore, we recorded the IcECG with
a guidewire with an insulated
polymer cover to overcome these
disadvantages caused by usage of
the over-the-wire catheters.
In most cases, ST-segment elevation appeared during bal-
oon inflation and resolved promptly after deflation of the
alloons. Previous studies have reported that persistent ST-
egment elevation after the balloon deflation was observed in
ome cases (9). In our own experience, persistent ST-segment
levation in the IcECG compared with the baseline IcECG
as recorded occasionally after successful PCI without surface
CG abnormality. Thus, we postulate persistent ST-segment
levation in the IcECG reflected local myocardial injury after
he PCI. Therefore, we designed this study to evaluate the
elation between post-procedural ST-segment elevation in the
cECG and the elevation of biochemical markers of myocar-
ial injury after elective PCI compared with surface ECG.
ethods
tudy population. From September 2004 to December
bbreviations
nd Acronyms
K-MB  creatine
inase-MB
cECG  intracoronary
lectrocardiogram
CI  percutaneous
oronary intervention
IMI  Thrombolysis In
yocardial Infarction
nT  troponin-T006, 339 consecutive patients who underwent apparentlyuccessful elective coronary stent implantations in Chubu
osai Hospital, Nagoya, Japan, were enrolled in this study,
hich was approved by the ethics committee of the hospital.
ll had angina, documented myocardial ischemia, or both
nd signed informed consent for the study. The exclusion
riteria of this study were patients with: 1) emergency
oronary angioplasty within 24 h of onset; 2) elevated
re-procedural cardiac biomarker; 3) active congestive heart
ailure; 4) severe lesion characteristics not suitable for
oft-tip guidewire; 5) angioplasty with debulking device
directional coronary atherectomy or rotational atherec-
omy); 6) Thrombolysis In Myocardial Infarction (TIMI)
ow grade 1 to 2 of target vessel at the end of procedure;
nd 7) multivessel stenting in a single procedure. This study
as approved by the ethics committee of our hospital.
Figure 1. IcECG
Representative intracoronary electrocardiogram (IcECG) waves of the left
anterior descending artery with a conventional uninsulated guidewire with
over-the-wire system (A) and without an over-the-wire systems (B), with a
polymer-covered guidewire with an over-the-wire system (C) and without
over-the-wire systems (D). All IcECGs were recorded with a paper speed of
50 mm/s and a calibration of 10 mm  1 mV.
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129tudy protocol. The study protocol was as follows. First, we
ecorded the baseline surface ECG and IcECG after posi-
ioning the guidewire in the distal part of a target vessel.
hen coronary stent implantation was performed after the
re-procedural coronary angiography and intravascular ul-
rasound (IVUS) recording. We also recorded post-
rocedural coronary angiography and IVUS. After confir-
ation of an uncomplicated PCI, we recorded the final
urface ECG and IcECG. Finally, we obtained blood
amples at approximately 18 h after the PCI to evaluate
ardiac biomarkers.
Angiography and IVUS were evaluated by an indepen-
ent investigator not involved in the procedures who is
naware of the final outcomes. A computerized quantitative
nalysis system (QCA-CMS system version 6.0.39.0, ME-
IS, Leiden, the Netherlands) was employed with the
uiding catheter for calibration. The IVUS studies were
erformed with a mechanical sector scanner (Atlantis SR
ro, Boston Scientific Corp., Natick, Massachusetts) and
otorized transducer pullback system (0.5 mm/s).
Figure 2. Representative IcECGs of Patient Without ST-Segment Elevation
There is no ST-segment change between baseline and post-procedural waves.
50 mm/s and a calibration of 10 mm  1 mV. LAD  left anterior descending coronCI procedure. All patients underwent elective coronary stent
mplantation with or without balloon pre-dilation. All patients
eceived antiplatelet agents, for at least 24 h before the
rocedure. Furthermore, 10,000 IU of heparin was adminis-
ered before the procedure, and an additional bolus of 1,000 to
,000 IU was given every hour if the procedure lasted for more
han 1 h. Patients without contraindication received ticlopidine
200 mg b.i.d.). No patient received glycoprotein IIb/IIIa
eceptor inhibitor, which is not approved in Japan. All proce-
ures were performed with 6- to 8-F guiding catheters by
ither a transradial or transfemoral approach. Successful PCI
efined as 50% residual stenosis with final TIMI flow grade
was performed in all the enrolled patients. Staff nurses in the
atheterization laboratory who were independent of this study
outinely recorded the presence or absence of chest pain after
he PCI in all patients. Post-procedural chest pain was defined
s varying degrees of typical or atypical chest pain at the end of
CI procedures.
cECG recording. A 0.014-inch diameter guidewire (Hi-
orque Balance Middle Weight-Universal, Abbott Vascu-
racoronary electrocardiograms (IcECGs) were recorded with a paper speed ofAll int
ary artery; RCA  right coronary artery.
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130ar; Santa Clara, California) was used. The proximal shaft of
his guidewire was coated with an insulated polymer cover
nd a distal uninsulated component was used as a unipolar
lectrode. The uninsulated tip of the guidewire was placed
t the distal epicardial position of the target lesion. The
ninsulated proximal end was connected to the chest lead
erminal (V1 lead) of RMC-3100 (Nihon Kohden, Tokyo,
apan). During IcECG recording, limb leads and chest leads
V2 to V6) of surface ECG were recorded simultaneously.
Intracoronary and surface ECG were calibrated (10 mm
1 mV) and recorded simultaneously. Baseline IcECG was
ecorded before usage of IVUS catheters, balloon catheters,
nd coronary stents crossing of target lesion. At the end of
CI, the guidewire was placed in the same position as the
aseline IcECG, and the final IcECG was recorded.
The IcECG waveforms of the left anterior descending
oronary artery with conventional uninsulated guidewire
ith and without over-the-wire catheter (bare wire) are
llustrated in Figures 1A and 1B. These waveforms changed,
epending on the tip position of the balloon catheter. On
Figure 3. Representative IcECGs of Patient With ST-Segment Elevation
Post-procedural IcECG shows ST-segment elevation compared with baseline el
and a calibration of 10 mm  1 mV. Abbreviations as in Figure 2.he contrary, the waveform of IcECG with the guidewire
ith a polymer cover was not influenced by use or disuse of
ver-the-wire catheter or by tip position of the balloon catheter
Figs. 1C and 1D). No adjunctive procedure or intracoronary
rug administration was done after recording the final IcECG.
valuation of cardiac biomarkers. Blood was sampled 18 h
fter the procedure. Serum troponin-T (TnT) was measured
ith an enzyme immunoassay kit (Roche Diagnostics,
okyo, Japan). The detection limit of this TnT assay system
s 0.03 ng/ml, and linearity is achieved from 0.1 to 2 ng/ml.
TnT level lower than 0.03 ng/ml was considered as
ng/ml and 0.03 to approximately 0.1 ng/ml was consid-
red as 0.1 ng/ml. A TnT level higher than 2 ng/ml is
onsidered as 2 ng/ml. We defined a post-procedural TnT
evel higher than 0.1 ng/ml, which was manufacturers’
linical cutoff value, as a post-procedural myocardial injury.
he CK-MB activity was measured with an immunoinhi-
ition assay kit (Sysmex, Kobe, Japan). Creatine phosphoki-
ase level was assessed with the UV-rate method (Daiichi
ure Chemicals, Tokyo, Japan).
ardiogram (ECG). All IcECG were recorded with a paper speed of 50 mm/sectroc
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131tatistics. All data are indicated in mean  SD values.
tatistical analysis was conducted with Stat-View 5.0 (SAS
nstitute, Cary, North Carolina). A comparison of contin-
ous variables was achieved with the unpaired Student t test
r a Mann-Whitney U test. Chi-square analysis or the
isher exact probability test was used for group comparison
f categorical variables. Univariate and multivariate logistic
egression analysis were constructed to evaluate the predic-
or of post-procedural positive TnT. Multivariate logistic
egression analysis was conducted to assess the clinical,
esion, and procedural factors associated with post-
rocedural TnT. Variables with a significance level of 0.2
n the univariate analysis and possible confounding factors
age, coronary risk factor, history of myocardial infarction,
nd de novo lesion) were considered to be candidate
ariables for inclusion in the multivariable analysis. Differ-
Table 1. Clinical Characteristics of Patients With ST-Segment Elevation
in the IcECG and Without ST-Segment Elevation
ST-Segment
Elevation ()
ST-Segment
Elevation () p Value
Number of patients 274 65
Male 182 (66.4%) 43 (66.2%) 0.99
Age, yrs 69.6 8.5 69.9 9.2 0.83
Diabetes mellitus 155 (56.9%) 38 (58.5%) 0.89
Hypertension 202 (73.7%) 51 (78.5%) 0.53
Hyperlipidemia 186 (67.9%) 49 (75.4%) 0.30
Obesity 98 (35.8%) 17 (26.2%) 0.18
Smoking 75 (27.4%) 17 (26.2%) 0.97
Previous infarction 79 (28.8%) 12 (18.5%) 0.12
Hemodialysis 5 (1.8%) 3 (4.6%) 0.38
History of ACS 73 (26.6%) 20 (30.8%) 0.61
LVEF 50% 30 (10.9%) 6 (9.2%) 0.86
Aspirin 249 (90.9%) 59 (90.8%) 0.99
Calcium antagonists 105 (38.3%) 27 (41.5%) 0.74
Beta-blocker drugs 113 (41.2%) 27 (41.5%) 0.99
Nitrates 110 (40.1%) 26 (40.0%) 0.99
Statins 138 (50.4%) 28 (43.1%) 0.36
ARB 94 (34.3%) 21 (32.3%) 0.87
ACEi 44 (16.1%) 10 (15.4%) 0.99
Insulin 39 (14.2%) 14 (21.5%) 0.20
Systolic blood pressure (mm Hg) 138.0 28.8 140.8 29.4 0.56
GFR (ml/min/1.73 m2 BSA) 72.4 24.1 65.6 22.2 0.04
Total cholesterol (mg/dl) 193.0 37.8 201.9 44.0 0.33
HDL cholesterol (mg/dl) 45.1 15.8 45.8 17.3 0.44
Triglyceride (mg/dl) 161.8 110.4 167.5 82.3 0.66
LDL cholesterol (mg/dl) 107.4 29.4 119.5 28.8 0.29
HbA1c (%) 6.5 1.5 6.5 1.3 0.57
Values are mean SD or n (%) of patients.
ACEi  angiotensin converting enzyme inhibitor; ACS  acute coronary syndrome;
ARB angiotensin-II receptor blocker; BSA body surface area; GFR glomerular filtration rate;
HbA1chemoglobinA1c; HDLhigh-density lipoprotein; IcECG intracoronary electrocardio-
gram; LDL low-density lipoprotein; LVEF left ventricular ejection fraction.nces were considered significant at p  0.05.esults
ost-procedural ST-segment elevation in the IcECG. Post-
rocedural ST-segment elevation in the IcECG was re-
orded in 65 (19.2%) patients. In 59 (91%) of these patients,
o surface ECG change was observed. In 6 patients,
T-segment elevation was recorded in surface and IcECG.
epresentative IcECG of patients with ST-segment eleva-
ion and without ST-segment elevation were shown in
igures 2 and 3.
linical, lesion, and procedural characteristics. Demographic
ata of the study population are presented in Table 1. No
tatistically significant differences existed between the 2
roups, except that the glomerular filtration rate level of
atients with ST-segment elevation in the IcECG was
ower than in patients without ST-segment elevation.
Detailed lesion and procedural characteristics are pre-
ented in Table 2. Lesion lengths of patients with ST-
egment elevation in the IcECG were significantly longer
han patients without changes.
ost-procedural cardiac biomarkers. Cardiac biomarkers of
ach group were demonstrated in Figure 4. Post-procedural
nT, CK-MB, and creatine phosphokinase were signifi-
antly higher in patients with ST-segment elevation in the
cECG (0.34  0.47 vs. 0.06  0.09, p  0.001, 27.7 
Table 2. Lesion and Procedural Characteristics of Patients With ST-
Segment Elevation in the IcECG and Without ST-Segment Elevation
ST-Segment
Elevation ()
ST-Segment
Elevation () p Value
Number of lesions 274 65
Target: LAD 126 (46.0%) 27 (41.5%) 0.39
Diagonal branch 2 (0.8%) 1 (1.7%) 0.46
Target: RCA 104 (38.0%) 25 (38.5%) 0.61
Target: LCX 41 (15.0%) 13 (20.0%) 0.57
Restenotic 39 (14.2%) 8 (12.3%) 0.84
Type B2/C 98 (35.8%) 31 (47.7%) 0.09
QCA: RD (mm) 2.53 0.68 2.39 0.65 0.29
QCA: MLD (mm) 1.36 0.31 0.81 0.42 0.28
QCA: %DS (%) 58.5 22.3 63.7 18.3 0.14
IVUS: lesion length (mm) 17.0 9.5 21.4 12.4 0.02
IVUS : lesion EEM (mm2) 9.77 4.36 9.73 3.71 0.94
Direct stenting 57 (20.8%) 15 (23.1%) 0.81
Number of stents (n) 1.34 0.66 1.48 0.69 0.13
Max ballooning pressure (atm) 14.6 7.0 14.3 7.8 0.79
Total ballooning time (s) 143.3 103.3 161.9 114.0 0.21
Stent length (mm) 23.6 13.0 27.0 14.0 0.06
Values are mean SD or n (%) of patients.
%DS  percent diameter stenosis; EEM  external elastic membrane-cross-sectional area;
IcECG  intracoronary electrocardiogram; IVUS  intravascular ultrasound; LAD  left anterior
descending coronary artery; LCX  left circumflex coronary artery; MLD  minimum lumen
diameter; Max  maximum; QCA  quantitative coronary angiography; RCA  right coronary
artery; RD reference diameter; Type B2/C American Heart Association/American College ofCardiology classification type B2 or type C.
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1327.5 vs. 15.7 13.7, p 0.001, and 196.8 240.2 vs. 90.0
60.2, p  0.001, respectively).
ssociation between post-procedural chest pain and ST-
egment elevation in IcECG. The ST-segment elevation in
he IcECG was recorded in 25 (54.3%) patients with
ost-procedural chest pain and in 40 (13.7%) patients
ithout chest pain (p  0.001). Surface ECG change was
ecorded in 5 (10.9%) patients with post-procedural chest
ain.
redictor of post-procedural myocardial injury. The inde-
endent predictors of positive TnT were glomerular filtra-
ion rate, lesion length, and ST-segment elevation in the
cECG in multiple logistic regression analysis (Table 3).
ensitivity, specificity, positive predictive value, and nega-
ive predictive value of ST-segment elevation in the IcECG,
ost-procedural chest pain, and surface ECG change for
redicting post-procedural troponin elevation are shown in
able 4. Sensitivity and specificity of ST-segment elevation
f IcECG were 54.9% and 92.2%, respectively. As com-
ared with surface ECG, IcECG shows significantly higher
ensitivity for positive TnT.
ngiographic and clinical outcomes. The incidence of an-
iographic complication, post-procedural, and the incidence
f in-hospital major adverse cardiac events (defined as
yocardial infarction and cardiac death) are shown in Table
. A higher incidence of angiographic and clinical compli-
ations in patients with ST-segment elevation of IcECG
as demonstrated.
iscussion
ajor ﬁndings. In this study, we demonstrated that inci-
ence of ST-segment elevation in the IcECG after success-
ul elective PCI amounted to approximately 19%. We also
howed the association between ST-segment elevation in
he IcECG and the higher level of post-procedural cardiac
iomarkers.
cECG recording. A previous study demonstrated that
cECG is more sensitive compared with surface ECG for
etecting myocardial ischemia during the PCI procedure
7,8). The ST-segment elevation in the IcECG after bal-
oon deflation was documented, but the actual incidences
nd clinical significance of this phenomenon were not
ell-described. In this study, we recorded post-procedural
T-segment elevation in the IcECG without surface ECG
hange in 17% of the study population. Conversely, change
f surface ECG without ST-segment elevation in the
cECG was recorded in 3 patients (1%). The IcECG is
ore sensitive and specific for detection of post-procedural
yocardial injury of the treated area than surface ECG.
ost-procedural myocardial injury and IcECG. Significant
ost-procedural myocardial injury with cardiac biomarker
levation is not uncommon after apparently successfulFigure 4. Cardiac Biomarkers of Patients With ST-Segment Elevation in
the IcECG and Without ST-Segment Elevation
Post-procedural troponin-T (TnT), creatine kinase-MB isozyme (CK-MB) and
creatine phosphokinase (CPK) were signiﬁcantly higher in patients with ST-CI (2,11). Contrast-enhanced MRI revealed myocardial
n
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133ecrosis in patients with post-procedural CK-MB eleva-
ion (12). It is well-known that surface 12-lead ECG is
ather insensitive for detecting minor myocardial injury.
eft ventricular electromechanical mapping demon-
trated evidences of electromechanical changes after suc-
essful PCI (13). We demonstrated that monitoring
T-segment changes of IcECG is a speedy and econom-
cal method for identifying risks of cardiac injuries after
he PCI procedures in the catheterization laboratory.
The mechanism of myocardial injury after a successful
CI is debatable. Several factors that are related to post-
Table 3. Univariate and Multivariate Predictors of Post-Procedural
Troponin-T Elevation After Coronary Stenting
OR (95% CI) p Value
Variables (univariate)
ST-segment elevation of IcECG 14.4 (7.67–14.4) 0.001
Lesion length (IVUS, mm) 1.04 (1.01–1.06) 0.001
Chest pain 3.56 (1.87–6.78) 0.001
GFR (ml/min/1.73 m2 BSA) 0.98 (0.97–0.99) 0.002
Statins 0.67 (0.41–1.11) 0.12
Hypertension 1.54 (0.84–2.85) 0.16
ST-segment elevation of surface ECG 2.02 (0.64–6.36) 0.23
Previous myocardial infarction 1.37 (0.80–2.36) 0.25
Age 1.02 (0.99–1.05) 0.31
Smoking 1.30 (0.75–2.27) 0.35
Obesity 1.13 (0.66–1.93) 0.66
Restenotic lesion 0.95 (0.46–1.97) 0.89
Hyperlipidemia 1.01 (0.59–1.74) 0.96
Variables (multivariate)
ST-segment elevation of IcECG 12.8 (6.14–26.64) 0.001
GFR (ml/min/1.73 m2 BSA) 0.98 (0.96–0.99) 0.01
Lesion length (IVUS, mm) 1.03 (1.00–1.05) 0.07
Hyperlipidemia 0.63 (0.30–1.33) 0.23
Previous myocardial infarction 1.54 (0.70–3.40) 0.28
Chest pain 1.54 (0.62–3.82) 0.35
Statins 0.71 (0.370–1.36) 0.31
Restenotic lesion 0.68 (0.25–1.87) 0.46
Age 0.98 (0.94–1.03) 0.48
Diabetes 1.19 (0.56–2.52) 0.65
Smoking 1.21 (0.44–3.29) 0.72
Obesity 1.13 (0.56–2.28) 0.72
Hypertension 0.98 (0.43–2.23) 0.97
CI confidence interval; IVUS intravascular ultrasound;ORodds ratio; other abbreviations as
in Table 1.
Table 4. Prediction of Post-Procedural Troponin-T Elevation After Stenting
Sensitivity Sp
ST-segment elevation of IcECG 54.9%
Persistent chest pain 26.8%
Surface ECG change 6.1%IcECG intracoronary electrocardiogram; NPV negative predictive value; PPV positive predictive valurocedural cardiac biomarker elevation were indicated, such
s plaque burden of the target lesion, lesion length, side
ranch occlusion, platelet-monocyte aggregate, age, du-
ation of balloon inflation, number of stents deployed,
tent expansion adjunctive to debulking devices, and
tatin administration (3,14–18). These findings suggested
rocedure-related microembolization is an important mech-
nism of biomarker elevation.
Recently, remarkably low restenosis rates of drug-
luting stents were demonstrated, and usage of coronary
tents rapidly increased. Coronary stents might increase
isks of post-procedural myocardial injury due to side
ranch occlusion and distal embolism. Larger stent ex-
ansion associated with a higher level of post-procedural
K-MB suggests a trade-off between optimal stent
mplantation and post-procedural myocardial injury (19).
herefore distal protection devices and an aspiration
ystem were introduced to prevent embolization during
CI for acute myocardial infarction patients or saphe-
ous vein graft interventions (20,21). Some studies dem-
nstrated that intravenous nicorandil administration re-
uced cardiac biomarker elevation after coronary stenting
rocedures or primary PCI (22,23). Evaluation of IcECG
ight provide useful information on indicating and
onitoring of these interventions.
Recently Balian et al. (24) demonstrated that intra-
oronary ST-segment shift after a successful PCI was
ssociated with post-procedural myocardial injury and
orse clinical outcome. Our study showed results similar
o this report surveyed around the same period. Addi-
ionally we also demonstrated usefulness of a polymer-
overed uninsulated guidewire and association with ST-
egment elevation in IcECG and persistent chest pain
fter the procedure.
CG, Surface ECG, and Post-Procedural Persistent Chest Pain
ity PPV NPV p Value
69.2% 86.5% 0.001
47.8% 79.5% 0.001
38.5% 76.4% 0.31
Table 5. Angiographic and In-Hospital Outcomes
ST-Segment
Elevation ()
ST-Segment
Elevation () p Value
Large side branch occlusion 1 (0.4%) 4 (6.2%) 0.01
Distal embolism 1 (0.4%) 3 (4.6%) 0.01
Transient slow ﬂow during procedure 15 (5.5%) 17 (26.2%) 0.01
In-hospital MACE 1 (0.4%) 5 (7.7%) 0.01
MACEmajor adverse cardiac event.by IcE
ecific
92.2%
90.7%
96.9%e.
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134hest pain after successful PCI and IcECG ﬁndings. Persistent
hest pain after a successful PCI was not uncommon in
atients without angiographic complications. Recently, an
ssociation between post-procedural chest pain and myo-
ardial injury with enzyme elevation after the PCI procedure
as demonstrated (25). In this study, a higher incidence of
T-segment elevation in IcECG was demonstrated in
atients with chest pain after PCI than in those without
hest pain. An association between post-procedural chest
ain and TnT elevation was also demonstrated in this study.
herefore, this finding indicated that minor myocardial
njury might play an important role in the development of
ost-procedural chest pain.
tudy limitations. A major limitation of this study is the fact
hat the definition of ST-segment elevation in the IcECG
hat reflects local myocardial ischemia has not been estab-
ished. The shift of distal-tip position can induce an
pparent change of IcECG waveform such as T-wave
nversion or change of amplitude of QRS complex. Thus,
e defined persistent ST-segment elevation in the IcECG
s an ischemic change. However, ST-segment shifts defined
s an elevation or depression of ST-segment 1 mm
ompared with the baseline allowed more sensitive identi-
cation (74% sensitivity) of post-procedural myocardial
njury (24).
Glycoprotein IIb/IIIa receptor inhibitors have shown to
educe the morbidity and mortality of patients undergoing
igh-risk PCI (26,27). A previous study demonstrated
lycoprotein IIb/IIIa receptor inhibitor administration re-
uced the incidence of post-procedural cardiac biomarker
levation (28). Thus, we speculated that administration of
hese drugs have an influence on the appearance of ST-
egment elevation in the IcECG. Although many evidences
upport the benefit of these drugs for patients with PCI,
one of the patients in this study population had been
dministered these drugs, because they are yet to be ap-
roved in our country.
onclusions
ntracoronary ECG provides useful information predicting
ost-procedural myocardial injury easily and inexpensively
n patients who have undergone apparently successful PCI
rocedures. An association between ST-segment elevation
f IcECG and persistent chest pain after procedures sug-
ested that a minor ischemic event might be a potential
echanism of persistent chest pain.
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